Home > Report on the risk assessment of 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) in the framework of the Council Decision on new psychoactive substances.

European Monitoring Centre for Drugs and Drug Addiction, Europol. [EMCDDA] (2018) Report on the risk assessment of 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union. 60 p.

[img]
Preview
PDF (Risk assessment CUMYL-4CN-BINACA)
1MB

This publication presents the data and findings of the risk assessment on 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) (a synthetic cannabinoid receptor agonist (synthetic cannabinoid) originally patented under the code name SGT-78)., carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017. On the basis of the Risk Assessment Report — and on the initiative of the European Commission — on 14 May 2018, the Council decided that CUMYL-4CN-BINACA should be subject to control measures across the Member States.

Table of contents:
· Foreword
· EMCDDA actions on monitoring and responding to new drugs
· Europol–EMCDDA Joint Report on CUMYL-4CN-BINACA (1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) — a summary
· Risk Assessment Report on a new psychoactive substance: 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA)
· Technical report on 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA)
· Participants of the risk assessment meeting, 7-8 November 2017


Item Type:Evidence resource
Publication Type:Guideline
Drug Type:Cannabis, New psychoactive substance
Intervention Type:AOD disorder harm reduction
Source:EMCDDA
Date:May 2018
Pages:60 p.
Publisher:Publications Office of the European Union
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction, Europol
Place of Publication:Luxembourg
EndNote:View
Related URLs:
Subjects:B Substances > Cannabis product (synthetic cannabinoids)
B Substances > New (novel) psychoactive substances
J Health care, prevention and rehabilitation > Risk and needs assessment > Risk assessment
L Social psychology and related concepts > Legal availability or accessibility
VA Geographic area > Europe

Repository Staff Only: item control page